Fifth Third Bancorp lessened its stake in Cabot Corporation (NYSE:CBT – Free Report) by 5.7% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 14,367 shares of the specialty chemicals company’s stock after selling 875 shares during the quarter. Fifth Third Bancorp’s holdings in Cabot were worth $1,078,000 at the end of the most recent reporting period.
A number of other large investors have also recently bought and sold shares of CBT. QRG Capital Management Inc. acquired a new position in shares of Cabot in the 1st quarter valued at approximately $482,000. SG Americas Securities LLC acquired a new position in Cabot during the first quarter valued at approximately $1,102,000. GAMMA Investing LLC lifted its stake in Cabot by 26.1% during the first quarter. GAMMA Investing LLC now owns 1,700 shares of the specialty chemicals company’s stock worth $141,000 after purchasing an additional 352 shares during the last quarter. KBC Group NV boosted its holdings in shares of Cabot by 31.5% in the 1st quarter. KBC Group NV now owns 2,690 shares of the specialty chemicals company’s stock valued at $224,000 after purchasing an additional 644 shares in the last quarter. Finally, Janney Montgomery Scott LLC bought a new position in shares of Cabot in the 1st quarter valued at $975,000. 93.18% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Separately, UBS Group set a $82.00 price objective on Cabot and gave the stock a “neutral” rating in a research report on Tuesday, August 5th. One equities research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $92.33.
Cabot Stock Up 2.4%
Shares of CBT opened at $77.33 on Monday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.41 and a current ratio of 2.13. Cabot Corporation has a 52 week low of $70.40 and a 52 week high of $117.46. The stock has a market capitalization of $4.11 billion, a price-to-earnings ratio of 10.11 and a beta of 0.90. The stock has a fifty day moving average of $78.29 and a 200-day moving average of $77.81.
Cabot (NYSE:CBT – Get Free Report) last issued its quarterly earnings data on Monday, August 4th. The specialty chemicals company reported $1.90 earnings per share for the quarter, topping analysts’ consensus estimates of $1.80 by $0.10. Cabot had a return on equity of 25.68% and a net margin of 11.14%.The business had revenue of $923.00 million for the quarter, compared to analyst estimates of $957.29 million. Cabot has set its FY 2025 guidance at 7.150-7.500 EPS. As a group, sell-side analysts anticipate that Cabot Corporation will post 7.57 earnings per share for the current fiscal year.
Cabot Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, September 11th. Investors of record on Friday, August 29th were issued a $0.45 dividend. This represents a $1.80 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date was Friday, August 29th. Cabot’s dividend payout ratio (DPR) is 23.53%.
Insider Buying and Selling
In other Cabot news, CEO Sean D. Keohane sold 114,436 shares of the business’s stock in a transaction that occurred on Thursday, August 14th. The shares were sold at an average price of $79.28, for a total transaction of $9,072,486.08. Following the sale, the chief executive officer directly owned 361,518 shares of the company’s stock, valued at $28,661,147.04. The trade was a 24.04% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 3.03% of the stock is currently owned by corporate insiders.
About Cabot
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
See Also
- Five stocks we like better than Cabot
- What Do S&P 500 Stocks Tell Investors About the Market?
- SoundHound Breaks Critical Resistance: How High Can It Get Now?
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Klarna IPO: BNPL Stock or Something Bigger?
- Basic Materials Stocks Investing
- Why Teradyne Is a Core Play in the AI Hardware Boom
Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBT – Free Report).
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.